Record

Reference numberEC/2012/10
LevelItem
TitleFitzGerald, Garret: certificate of election to the Royal Society
Date28 September 2010
DescriptionCertificate of Election
CitationDr. FitzGerald's research has been characterized by an integrative approach to elucidating the mechanisms of drug action. He was the first to describe the dose dependent suppression by aspirin of thromboxane and prostacyclin biosynthesis in vivo. His work contributed substantially to the development of low-dose aspirin. FitzGerald's group was the first to predict and then mechanistically explain the cardiovascular hazard from NSAIDs. Aside from this work, FitzGerald has also discovered many products of lipid peroxidation and established their utility as indices of oxidant stress in vivo. His laboratory was the first to discover a molecular clock in the cardiovascular system and has contributed substantially to our understanding of the importance of peripheral clocks in the regulation of cardiovascular and metabolic function
Extent4p
Access statusClosed
Add to My Items

    Collection highlights

    Browse the records of some of our collections, which cover all branches of science and date from the 12th century onwards. These include the published works of Fellows of the Royal Society, personal papers of eminent scientists, letters and manuscripts sent to the Society or presented at meetings, and administrative records documenting the Society's activities since our foundation in 1660.

    The Royal Society

    The Royal Society is a Fellowship of many of
    the world's most eminent scientists and is the
    oldest scientific academy in continuous existence.
    Registered charity number 207043

    Website design ©CalmView



    CONTACT US

    + 44 207 451 2500
    (Lines open Mon-Fri, 9:00-17:00. Excludes bank holidays)

    6-9 Carlton House Terrace, London SW1Y 5AG

    Email Us →

    SUBSCRIBE

    Subscribe to our newsletters to be updated with the
    latest news on innovation, events, articles and reports.

    Subscribe →

    © CalmView